logo
Nicola Lyons appointed Group Chief Human Resources Officer at Getlink

Nicola Lyons appointed Group Chief Human Resources Officer at Getlink

Business Wire4 days ago

PARIS--(BUSINESS WIRE)--Regulatory News:
Nicola Lyons joins Getlink (Paris:GET) as Group Chief Human Resources Officer and, as such, becomes a member of the Executive Committee. She will lead the Group's human resources strategy and key projects, including training, career development, recruitment and integration, as well as diversity and inclusion.
Yann Leriche, Chief Executive Officer of Getlink, said: 'I am delighted to welcome Nicola Lyons. Her background in a variety of European cultural environments will be an asset in implementing the development plans of a group such as ours. Her knowledge of logistics and freight transport companies will be invaluable in achieving operational excellence.'
With over 20 years of experience in international companies, Nicola Lyons has in-depth knowledge of the freight and logistics sectors.
She began her career in 2001 in London with the Bouygues Group before joining the Fujitsu Group in 2005, where she gained promotion to Deputy Director of Human Resources. In 2009, she joined the industrial logistics company GEFCO as Human Resources Manager for the United Kingdom, a role she took on for the Benelux region in 2012. In 2015, she moved into global roles, first based in Paris, then in the Netherlands, for the Freight Forwarding (Air & Sea) division. Returning to Paris in 2020, she became Chief Human Resources Director for the EMEA region and then Chief Human Resources Director for the Integrated Logistics division. In 2022, she was appointed SVP Human Resources for Europe at the logistics and supply chain company CEVA Logistics (CMA-CGM Group).
Nicola Lyons is a graduate of the University of West London (Applied Languages) and Coventry University (Human Resources).
For the composition of the Getlink Executive Committee, please see: https://www.getlinkgroup.com/en/our-group/corporate-governance/executive-committee/
About Getlink
Getlink SE (Euronext Paris: GET), through its subsidiary Eurotunnel, is the concession holder until 2086 for the Channel Tunnel infrastructure and operates Truck Shuttles and Passenger Shuttles (cars and coaches) between Folkestone (UK) and Calais (France). Since 31 December 2020 Eurotunnel has been developing the smart border to ensure that the Tunnel remains the fastest, most reliable, easiest and most environmentally friendly way to cross the Channel. Since it opened in 1994, more than 518 million people and 106 million vehicles have travelled through the Channel Tunnel. This unique land link, which carries a quarter of trade between the Continent and the United Kingdom, has become a vital link, reinforced by the ElecLink electricity interconnector installed in the Tunnel, which helps to balance energy needs between France and the United Kingdom. Getlink completes its sustainable mobility services with its rail freight subsidiary Europorte. Committed to "low-carbon" services that control their impact on the environment, Getlink has made the place of people, nature and territories a central concern.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SmartStop Self Storage REIT, Inc. to Join the Russell 3000 Index
SmartStop Self Storage REIT, Inc. to Join the Russell 3000 Index

Business Wire

time26 minutes ago

  • Business Wire

SmartStop Self Storage REIT, Inc. to Join the Russell 3000 Index

LADERA RANCH, Calif.--(BUSINESS WIRE)--SmartStop Self Storage REIT, Inc. ('SmartStop') (NYSE: SMA), an internally managed real estate investment trust and a premier owner and operator of self-storage facilities in the United States and Canada, will be added to the Russell 3000® Index following the annual reconstitution of the Russell indexes, effective after the market closes on Friday, June 27, 2025. SmartStop's inclusion follows its April 2025 listing on the New York Stock Exchange and marks a significant achievement in its growth as a publicly traded enterprise. The Russell 3000 Index captures the largest 3,000 U.S.-traded stocks by market capitalization and serves as the foundation for additional subindexes, including the Russell 1000® and Russell 2000® Indexes. Final placement in one of these subindexes will be based on SmartStop's relative market capitalization. 'Joining the Russell indexes is a significant milestone for SmartStop as a newly listed company,' said H. Michael Schwartz, Chairman and CEO of SmartStop. 'It reflects the progress we've made and the scale of our platform. We believe this inclusion will help increase our visibility among institutional investors as we continue executing our growth strategy.' About SmartStop Self Storage REIT, Inc. (SmartStop): SmartStop Self Storage REIT, Inc. ('SmartStop') (NYSE:SMA) is a self-managed REIT with a fully integrated operations team of approximately 590 self-storage professionals focused on growing the SmartStop® Self Storage brand. SmartStop, through its indirect subsidiary SmartStop REIT Advisors, LLC, also sponsors other self-storage programs. As of May 30, 2025, SmartStop has an owned or managed portfolio of 221 operating properties in 23 states, the District of Columbia, and Canada, comprising approximately 157,600 units and 17.7 million rentable square feet. SmartStop and its affiliates own or manage 41 operating self-storage properties in Canada, which total approximately 34,400 units and 3.5 million rentable square feet. Additional information regarding SmartStop is available at

Cresco Labs Continues Track Record of Delivering Strong Operating Cash Flow
Cresco Labs Continues Track Record of Delivering Strong Operating Cash Flow

Business Wire

time28 minutes ago

  • Business Wire

Cresco Labs Continues Track Record of Delivering Strong Operating Cash Flow

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (' Cresco Labs ' or the ' Company '), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the first quarter ended and year ended March 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here. First Quarter 2025 Highlights First quarter revenue of $166 million. First quarter operating cash flow of $30 million and Free Cash Flow 1 of $25 million. Gross profit of $79 million. Adjusted gross profit 1 of $82 million; and an Adjusted gross margin 1 of 49% of revenue. SG&A of $58 million or 35% of revenue. Net loss of $15 million. First quarter Adjusted EBITDA 1 of $36 million and Adjusted EBITDA margin 1 of 22%. Retained the No. 1 share position in multiple billion dollar markets. 2 Management Commentary "We entered 2025 with the flexibility and financial strength needed to navigate market volatility, complete our debt refinancing, and remain both strategic and patient as we invest thoughtfully for long-term growth." In Q1, we delivered $166 million in revenue, reflecting our successful plan to reduce AR exposure by limiting sales to wholesale accounts with credit risk. We generated $82 million in adjusted gross profit, and $36 million in Adjusted EBITDA. Most importantly, these actions translate into strong cash results. We generated $30 million in operating cash flow and ended the quarter with $162 million in cash, our highest balance in the past three years. "We're focused on ensuring our balance sheet remains in the strongest possible position to support long-term value creation," said Charlie Bachtell, Cresco Labs CEO and co-founder. "By staying disciplined and thoughtful in how we deploy capital, we're positioning Cresco Labs to drive margin expansion, gain market share, and invest in sustainable growth when the right opportunities arise." Balance Sheet, Liquidity, and Other Financial Information As of March 31, 2025, current assets were $311 million, including cash, cash equivalents, and restricted cash of $159 million. The Company had senior secured term loan debt, net of discount and issuance costs, of $353 million and a mortgage loan, net of discount and issuance costs of $18 million. Total shares on a fully converted basis to Subordinate Voting Shares were 484,592,240 as of March 31, 2025. Conference Call and Webcast The Company will host a conference call and webcast to discuss its financial results on Monday, June 2, 2025, at 8:30am Eastern Time (7:30am Central Time). The conference call may be accessed via webcast or by dialing 1-833-470-1428 (US Toll Free) or 1-404-975-4839 (US Local), providing access code 671160. Archived access to the webcast will be available for one year on Cresco Labs' investor website, here. Consolidated Financial Statements The financial information reported in this press release is based on unaudited management prepared financial statements for the quarter ended March 31, 2025. These financial statements have been prepared in accordance with U.S. GAAP. The Company expects to file its unaudited condensed interim consolidated financial statements for the quarter ended March 31, 2025, on SEDAR+ and EDGAR on or about May 30, 2025. Accordingly, such financial information may be subject to change. All financial information contained in this press release is qualified in its entirety with reference to such financial statements. While the Company does not expect there to be any material changes between the information contained in this press release and the consolidated financial statements it files on SEDAR+ and EDGAR, to the extent that the financial information contained in this press release is inconsistent with the information contained in the Company's financial statements, the financial information contained in this press release shall be deemed to be modified or superseded by the Company's filed financial statements. The making of a modifying or superseding statement shall not be deemed an admission, for any purposes, that the modified or superseded statement, when made, constituted a misrepresentation for purposes of applicable securities laws. Further, the reader should refer to the additional disclosures in the Company's audited financial statements for the year ended December 31, 2024, filed on SEDAR+ and EDGAR. Cresco Labs references certain non-GAAP financial measures throughout this press release, which may not be comparable to similar measures presented by other issuers. Please see the 'Non-GAAP Financial Measures' section below for more detailed information. Non-GAAP Financial Measures This release reports its financial results in accordance with U.S. GAAP and includes certain non-GAAP financial measures that do not have standardized definitions under U.S. GAAP. The non-GAAP measures include: Earnings before interest, taxes, depreciation, and amortization ('EBITDA'); Adjusted EBITDA; Adjusted EBITDA margin; Adjusted gross profit; Adjusted gross profit margin; Adjusted selling, general, and administrative expenses ('Adjusted SG&A'), Adjusted SG&A margin; and Free Cash Flow are non-GAAP financial measures and do not have standardized definitions under U.S. GAAP. The Company defines these non-GAAP financial measures as follows: EBITDA as net loss (income) before interest, taxes, depreciation, and amortization; Adjusted EBITDA as EBITDA less other (expense) income, net, fair value mark-up for acquired inventory, adjustments for acquisition and non-core costs, impairment and share-based compensation; Adjusted EBITDA Margin as Adjusted EBITDA divided by revenues, net; Adjusted gross profit as gross profit less fair value mark-up for acquired inventory and adjustments for acquisition and non-core costs; Adjusted gross profit margin as Adjusted gross profit divided by revenues, net; Adjusted SG&A as SG&A less adjustments for acquisition and non-core costs; Adjusted SG&A margin as Adjusted SG&A divided by revenues, net; and Free Cash Flow as Net cash provided by operating activities less purchases of property and equipment and proceeds from tenant improvement allowances. The Company has provided the non-GAAP financial measures, which are not calculated or presented in accordance with U.S. GAAP, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with U.S. GAAP and may not be comparable to similar measures presented by other issuers. These supplemental non-GAAP financial measures are presented because management has evaluated the financial results both including and excluding the adjusted items and believe that the supplemental non-GAAP financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. These supplemental non-GAAP financial measures should not be considered superior to, as a substitute for or as an alternative to, and should only be considered in conjunction with, the U.S. GAAP financial measures presented herein. Accordingly, the Company has included below reconciliations of the supplemental non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with U.S. GAAP. About Cresco Labs Inc. Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production, and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy's, and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development, and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs' journey by visiting or following the Company on Facebook, X or LinkedIn. Forward-Looking Statements This press release contains 'forward-looking information' within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute 'forward-looking statements' within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995 (collectively, 'forward-looking statements'). Such forward-looking statements are not representative of historical facts or information or current condition but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as, 'may,' 'will,' 'should,' 'could,' 'would,' 'expects,' 'plans,' 'anticipates,' 'believes,' 'estimates,' 'projects,' 'predicts,' 'potential,' or 'continue,' or the negative of those forms or other comparable terms. The Company's forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under 'Risk Factors' in the Company's Annual Information Form for the year ended December 31, 2024, filed on SEDAR+ and EDGAR, other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company's forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs' shares, nor as to the Company's financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company's forward-looking statements contained herein, whether as a result of new information, any future event, or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise. Cresco Labs Inc. Summarized Consolidated Statements of Financial Position As of March 31, 2025 and December 31, 2024 ($ in thousands) March 31, 2025 December 31, 2024 (unaudited) Cash, cash equivalents, and restricted cash (current) $ 158,867 $ 141,003 Other current assets 152,226 153,254 Property and equipment, net 338,399 344,846 Intangible assets, net 293,317 293,994 Goodwill 283,484 283,484 Other non-current assets 137,808 138,774 Total assets $ 1,364,101 $ 1,355,355 Total current liabilities $ 113,197 $ 94,338 Total non-current liabilities 875,335 872,841 Total shareholders' equity 375,569 388,176 Total liabilities and shareholders' equity $ 1,364,101 $ 1,355,355 Expand Cresco Labs Inc. Unaudited Reconciliation of SG&A to Adjusted SG&A (Non-GAAP) For the Three Months Ended March 31, 2025, December 31, 2024, and March 31, 2024 For the Three Months Ended ($ in thousands) March 31, 2025 December 31, 2024 March 31, 2024 Selling, general, and administrative $ 57,811 $ 56,030 $ 54,013 Adjustments for acquisition and other non-core costs 4,841 2,299 2,297 Adjusted SG&A (Non-GAAP) $ 52,970 $ 53,731 $ 51,716 Adjusted SG&A % (Non-GAAP) 32.0 % 30.5 % 28.1 % Expand Cresco Labs Inc. Unaudited Reconciliation of Net (Loss) Income to Adjusted EBITDA (Non-GAAP) For the Three Months Ended ($ in thousands) March 31, 2025 December 31, 2024 March 31, 2024 Net (loss) income 1 $ (15,234 ) $ 439 $ (2,055 ) Depreciation and amortization 12,906 13,904 15,331 Interest expense, net 14,824 13,079 14,071 Income tax expense 14,316 2,616 18,003 EBITDA (Non-GAAP) $ 26,812 $ 30,038 $ 45,350 Other (income) expense, net (317 ) 3,272 (856 ) Adjustments for acquisition and other non-core costs 7,015 4,493 4,470 Share-based compensation 2,723 3,705 4,197 Adjusted EBITDA (Non-GAAP) $ 36,233 $ 41,508 $ 53,161 Adjusted EBITDA % (Non-GAAP) 21.9 % 23.6 % 28.8 % 1 Net (loss) income includes amounts attributable to non-controlling interests. Expand Cresco Labs Inc. Unaudited Summarized Consolidated Statements of Cash Flows For the Three Months Ended March 31, 2025, December 31, 2024, and March 31, 2024 For the Three Months Ended ($ in thousands) March 31, 2025 December 31, 2024 March 31, 2024 Net cash provided by operating activities $ 30,463 $ 29,486 $ 36,471 Net cash used in investing activities (6,869 ) (3,013 ) (5,677 ) Net cash used in financing activities (5,733 ) (42,034 ) (11,149 ) Effect of foreign currency exchange rate changes on cash and cash equivalents 2 9 (13 ) Net increase in cash and cash equivalents $ 17,863 $ (15,552 ) $ 19,632 Cash and cash equivalents and restricted cash, beginning of period 144,255 159,806 108,520 Cash and cash equivalents and restricted cash, end of period $ 162,118 $ 144,254 $ 128,152 Expand Cresco Labs Inc. Unaudited Reconciliation of Operating Cash Flow to Free Cash Flow (Non-GAAP) For the Three Months Ended March 31, 2025, December 31, 2024, and March 31, 2024 For the Three Months Ended ($ in thousands) March 31, 2025 December 31, 2024 March 31, 2024 Net cash provided by operating activities $ 30,463 $ 29,486 $ 36,471 Purchases of property and equipment (5,818 ) (3,204 ) (3,782 ) Proceeds from tenant improvement allowances 50 439 478 Free Cash Flow (Non-GAAP) $ 24,695 $ 26,721 $ 33,167 Expand

The Week in Numbers: tariff whiplash, tech earnings
The Week in Numbers: tariff whiplash, tech earnings

Yahoo

time43 minutes ago

  • Yahoo

The Week in Numbers: tariff whiplash, tech earnings

STORY: From fresh whiplash over U.S. tariffs, to good news, bad news at Nvidia, this is the Week in Numbers. ::50% 50% was… and then wasn't set to be the U.S. tariff on EU products from June 1. Trump threatened to set that levy, frustrated by the pace of talks. But he then backed off after a call with European Commission chief Ursula Von der Leyen. Treasury Secretary Scott Bessent said tough talking had proved effective: 'And as we saw with the president's threat of 50% tariffs last Friday, the EU came to the table very quickly over the weekend. So now we've got the EU in motion also.' ::69% 69% was the surge in sales for Nvidia over the latest quarter. The news cheered markets, and sent shares higher. But the firm warned that U.S. curbs on shipments to China would cut $8 billion off sales in the coming period. That forced it to offer a forecast below Wall Street expectations. ::49% 49% was the plunge in European sales for Tesla in April. That drop came even as the region's overall market for EVs jumped. Analysts say the number suggests an updated Model Y crossover isn't boosting Tesla sales in Europe, where the brand has been hurt by Elon Musk's embrace of right-wing politics. ::$15.5 billion Almost $15.5 billion was the record revenue at Xiaomi. The all-time high comes as the phonemaker steps up its move into the car market. This week its YU7 SUV hit showrooms, aimed squarely at taking another chunk out of Tesla sales. ::$327 million And close to $327 million was the record box office for the top 10 films at North American cinemas over any Memorial Day weekend. Takings were boosted by the latest 'Mission: Impossible' blockbuster, as well as Disney's live-action remake of 'Lilo & Stitch'. The numbers offered a desperately needed boost for the movie industry, with ticket sales still below pre-pandemic levels.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store